Stockscreener 앱 받기
7.21
1.23%
-0.09
시간 외 거래:
7.21
Myriad Genetics Inc 주식(MYGN)의 최신 뉴스
Myriad Genetics Inc Stock Analysis and ForecastCapital Gains Strategies & High Profit Market Growth - earlytimes.in
Chart Watch: Why Myriad Genetics Inc stock could rally in 2025Weekly Investment Report & Low Drawdown Trading Strategies - moha.gov.vn
Will Breakout in GIC Housing Finance Limited Sustain Through Next WeekCapital Gains Strategies & Free Unmatched Market Gains - earlytimes.in
Myriad Genetics, Inc. $MYGN Stake Reduced by Camber Capital Management LP - MarketBeat
Discipline and Rules-Based Execution in MYGN Response - news.stocktradersdaily.com
Why Myriad Genetics (MYGN) Stock Is Up Today - Finviz
Myriad Genetics to Showcase Advances in Hereditary Cancer and MRD Testing at 2025 San Antonio Breast Cancer Symposium - Quiver Quantitative
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium - GlobeNewswire
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings? - TradingView
Prudential Financial Inc. Has $1.82 Million Stock Position in Myriad Genetics, Inc. $MYGN - MarketBeat
Fisher Asset Management LLC Purchases 219,607 Shares of Myriad Genetics, Inc. $MYGN - MarketBeat
What MACD trends signal for Myriad Genetics Inc. (MYD) stock2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser
Why Myriad Genetics Inc. stock appeals to analystsWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser
Can Myriad Genetics Inc. stock continue upward trendMarket Trend Review & Low Drawdown Trading Techniques - Newser
Why Is Myriad (MYGN) Up 8.7% Since Last Earnings Report? - MSN
Upcoming Virtual Meeting on December 11 Hosted by Craig-Hallum f - GuruFocus
4D Path’s Physics-Inspired QPOR™ Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial - GlobeNewswire Inc.
1 Healthcare Stock with Promising Prospects and 2 We Question - Barchart.com
How Myriad Genetics Inc. stock benefits from strong dollarTrade Risk Assessment & Low Drawdown Investment Ideas - Newser
Why Myriad Genetics (MYGN) Stock Is Trading Lower Today - Finviz
Myriad Genetics, Inc. $MYGN Stock Holdings Lifted by XTX Topco Ltd - MarketBeat
Myriad Genetics Outpaces Expectations But Faces Profit Challenges - Finimize
How Recent Developments Are Shaping the Myriad Genetics Investment Story - Yahoo Finance
UBS Initiates Coverage of Myriad Genetics (MYGN) with Neutral Recommendation - MSN
Will Myriad Genetics Inc. stock return to pre crisis levelsJuly 2025 Outlook & Breakout Confirmation Trade Signals - BỘ NỘI VỤ
Will Myriad Genetics Inc. stock attract more institutional investorsPortfolio Growth Summary & Real-Time Buy Signal Notifications - BỘ NỘI VỤ
Myriad Genetics, Inc. (MYGN) Stock Forecasts - Yahoo Finance
How Myriad Genetics achieved fast, accurate, and cost-efficient document processing using the AWS open-source Generative AI Intelligent Document Processing Accelerator - Amazon Web Services (AWS)
Earnings Recap: Can Myriad Genetics Inc. stock double in next 5 yearsTake Profit & Free Safe Entry Trade Signal Reports - BỘ NỘI VỤ
Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know - MSN
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health - The Manila Times
Clairity, Myriad Genetics, MagView partner on breast cancer risk tools By Investing.com - Investing.com Nigeria
Myriad Genetics partners to use AI to measure breast cancer risk - Seeking Alpha
Clairity, Myriad Genetics, MagView partner on breast cancer risk tools - Investing.com
Clairity, Myriad Genetics, and MagView Collaborate to Enhance Breast Cancer Risk Assessment Tool - Quiver Quantitative
Clairity, Myriad Genetics, Inc. and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health - marketscreener.com
Myriad Genetics (NASDAQ: MYGN), Clairity and MagView launch AI breast risk platform - Stock Titan
Myriad Genetics joins Forbes list of America's dream employers for 2026 - Traders Union
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Myriad Genetics Q3 2025 Earnings Preview - MSN
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know - Yahoo Finance
Can Myriad Genetics Inc. stock sustain market leadershipMarket Activity Report & Real-Time Volume Spike Alerts - newser.com
Is Myriad Genetics Inc. (MYD) stock nearing a technical breakout2025 Key Highlights & Detailed Earnings Play Strategies - newser.com
Will Myriad Genetics Inc. stock benefit from sector rotationJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
1.15%
0.39%
자본화:
|
볼륨(24시간):